Concepedia

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. II. Agonist and Antagonist Properties at Subtypes of Dopamine D2-Like Receptor and α1/α2-Adrenoceptor

Adrian Newman‐Tancredi, Didier Cussac, Valérie Audinot, Jean‐Paul Nicolas, Frédéric De Ceuninck, Jean A. Boutin, Mark J. Millan

Journal of Pharmacology and Experimental Therapeutics · 2002 · 180 citations · 48 references

DOI

Concepts

References

48

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

Olivier Guillin, Jorge Díaz, Patrick Carroll et al. · Nature · 2001 · 572 citations

, , +13

Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

Mark J. Millan, Lisa Maiofiss, Didier Cussac et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 483 citations · Full text

, , +17

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

Joachim Mierau, Franz J. Schneider, Helmut A. Ensinger et al. · European Journal of Pharmacology Molecular Pharmacology · 1995 · 257 citations

, , +16

In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors.

J W Kable, L. Charles Murrin, David B. Bylund · PubMed · 2000 · 205 citations

, , +14

Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions

Yanyan Wang, Rong Xu, Toshikuni Sasaoka et al. · Journal of Neuroscience · 2000 · 195 citations · Full text

, , +9